Correlation Between Number of Ovarian Cysts in Polycystic Ovary Syndrome and Anthropometric and Biochemical Factors..
- *Corresponding Author:
- Havagiray R Chitme
Oman Medical College, Post Box: 620, Postal Code: 130
Baushar Campus, Muscat, Sultanate of Oman
E-mail: [email protected]
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Polycystic ovary syndrome is one of the most common complex conditions characterised by presence of ovarian cysts in one side or both sides of the ovary. It is known to cause various health problems in women such as menstrual disorders, infertility, endocrine disturbance, insulin resistance and change in composition of body. Therefore present study was carried out to know whether there is any correlation between number of ovarian cysts in PCOS infertile patients and factors related to body composition, anthropometrics, insulin resistance, and insulin sensitivity. Present cross sectional study was carried out at a specialty medical centre for six months of period among sixty one infertile patients diagnosed with PCOS. Pearson correlation analysis has shown a significant (p<0.05) negative correlation between number of cysts and ideal body weight, and trunk skeletal muscle whereas it was negatively highly significant (p<0.01) with whole skeletal muscle and skeletal muscle to total fat ratio. Positive and significant (p<0.05) Pearson correlation was noted with arm subcutaneous fat whereas a highly significant (p<0.01) correlation was noted with total fat, whole subcutaneous fat and trunk subcutaneous fat. Linear regression analysis of the data shows a significant (p<0.05) relation between number of cysts and total body fat. Results of our study have shown no correlation between number of ovarian cysts and insulin activity directly. We conclude from this study that there is a significantly positive correlation between number of ovarian cysts and visceral fat, whole subcutaneous fat and trunk subcutaneous fat. We also conclude that a significantly negative correlation is seen between number of cysts and ideal body weight, skeletal muscle composition and skeletal muscle to fat ratio.
Anthropometrics, body composition, insulin resistance, ovarian cysts, PCOS
Polycystic ovary syndrome (PCOS) is as endocrine disorders affecting 10 to 15% of women of reproductive age group. Clinical manifestations of patients diagnosed with PCOS include menstrual irregularities, oligomenorrhea or anovulation, acne, hirsutism, hyperandrogenism and polycystic ovaries. It is also recorded to accompany with infertility, obesity, hypertension, insulin resistance and dylipidaemia.  Recently it is concluded that insulin as the key factor involved in metabolic and endocrine abnormalities leading to glucose intolerance and insulin resistance responsible for multifactorial, heterogeneous and complex complications.[4,5]
PCOS is also linked to family history of diabetes mellitus-II and PCOS and also said that it is majorly associated with increased basal glucagon and insulin due to parasympathetic stimulation of pancreatic islet cells long before the appearance of clinical manifestations. Development of insulin resistance in PCOS is proven to involve decreased glucose transport of adipocytes, decreased insulin receptor stimulation and hepatic clearance of insulin, increased pancreatic sensitivity, steroidogenesis,[7-9] and reduced muscular glucose transport.[10,11] On the other hand hyperinsulinemia is believed to stimulate secretion of androgen in ovarian and adrenal glands leading to an increase in androgen levels followed by increased GnRH pulse frequency.  Persistent pulsating GnRH increase LH secretion consequently stimulating ovarian theca cells and relative decrease in FSH secretion leading to decreased aromatization of androgens to estrogen further producing more androgens.[12,13] A study on prevalence of diagnosed PCOS cases among women in Oman is similar to that of other countries however relationship between PCOS and other metabolic factors is not yet studied. We hypothesize that identifying the correlation between number of ovarian cysts and metabolic and biochemical factors such as insulin resistance, insulin sensitivity and fasting serum glucose to insulin ratio[14,15] will assist in understanding the development of PCOS in women. Therefore, present cross-sectional study was conceived among infertile women with PCOS to know if there is any correlation between number of ovarian cysts and metabolic and biochemical factors.
Present study was a cross sectional hospital based study carried out by involving sixty one infertile Omani women diagnosed with PCOS. PCOS is defined in accordance to Rotterdam criteria. We excluded women with hypothyroidism, hyperthyroidism, liver failure, hyperprolactinemia, adrenal hyperplasia, diabetes, women receiving care with oral contraceptives, hypoglycaemics and anti-dyslipidaemics from the study. Clinical work was carried out at Al Bushra Medical Specialty Complex, Muscat. The clinic has provided access to laboratory data, case files by maintaining full confidentiality of all information accessed and also provided MOH licensed and trained laboratory technicians and nursing staff required for this study.
ELISA Insulin kit purchased from Wuhan Fine Biotech Co Ltd., China to estimate plasma insulin level. Skeletal muscle ratio and total body fat percentage were measured by using Omron HBF 375 Krada Scan Body Composition Monitor - Body Fat Analyser.
Anthropometric profile of participants including weight, height, waist circumference and hip circumference were recorded according to the study published very recently. Based on these recordings waist to hip ratio, body mass index (BMI) and ideal body weight (IBW) were calculated to correlate them to number of ovarian cysts.
Insulin and glucose profile
The fasting plasma glucose was measured along with plasma insulin. Plasma insulin was measured using ELISA Insulin kit EH374 by following the detailed instructions and procedures as provided with the kit. These values are used in calculating homeostatic model for insulin resistance (HOMA), fasting insulin resistance percentage, and quantitative insulin-sensitivity check index (QUICKI) and insulin sensitivity. Fasting plasma glucose level, 80 mg/dL; Fasting plasma insulin level, μ IU/mL; QUICKI, 0.384; HOMA, 1; Glucose/Insulin ratio, 16 are considered as normal in this study.
Assessment of skeletal muscle and body fat composition
Body fat and skeletal muscle composition and weight were measured by following the instructions supplied by Omron Body Composition analyser. Skeletal muscle ratio was calculated by the formula (100 x skeletal muscle mass/body weight). Body fat percentage was computed by using the formula (100 x body fat mass/body weight).[20,21] On the day of testing the patients were asked to have minimum eating and drinking and also limited physical activity within six hour before the test.
Study was approved by Institutional Ethics Committee as well as the clinic. Only those patients were involved who signed a letter of consent to participate after specifying objectives, assurance of privacy, anonymity and confidentiality. Scholars gave assurance that nonparticipation would not affect their care with a liberty to withdraw from the study at any point of time. All unused specimens were sensibly disposed according to the biosafety and medical guidelines followed at clinic.
The information collected from laboratory and data sheet were entered directly into SPSS version 19 (SPSS Inc. Chicago, IL, USA) and analysed by using descriptive statistics such as mean and standard deviation for continuous numerical data. Pearson’s correlation analysis and linear regression were used to correlate number of ovarian follicles and influencing factors. P values less than 0.05 were considered as statistically significant.
Correlation with anthropometric profile
As shown in the Table 1 the waist circumference of selected population was 97.44 ± 15.11 cm; waist/hip ratio 0.9 ± 0.14; body mass index was 28.2 ± 6.08 kg/m2 and Ideal Body Weight 55.15 ± 4.52 kg. The Pearson correlation analysis of results shown that there is a significant (P<0.05) negative correlation existed between number of ovarian cysts and ideal body weight. However, other factors such as waist circumference, waist/hip ratio, and body mass index are insignificantly but positively correlated.
|Factors||Mean ±SD||Pearson Correlation Analysis|
|Correlation||Level of Significance|
|Waist (cm)||97.44 ± 15.11||0.183||0.148|
|Waist Hip Ratio||0.9 ± 0.14||0.068||0.595|
|BMI||28.2 ± 6.08||0.141||0.281|
|Ideal Body Weight||55.15 ± 4.52||-0.261*||0.037|
|Glucose||101.18 ± 15.79||-0.085||0.503|
|Insulin||41.53 ± 29.45||0.132||0.332|
|Glucose/Insulin ratio||4.28 ± 5.68||-0.098||0.474|
|Fasting Insulin Resistance%||140.89 ±110.4||0.146||0.284|
|Skeletal muscle/ Fat ratio||39.95 ±12||-0.33**||0.008|
|Body Fat %||55.57 ±11.27||0.016||0.905|
|HOMA IR||8.69 ±6.81||0.129||0.342|
|Body Fat Composition|
|Fat||37.78 ± 8.57||0.347**||0.007|
|Visceral fat||9.11 ± 6.5||0.237||0.068|
|Whole subcutaneous fat||32.82 ± 5.65||0.315**||0.011|
|Trunk subcutaneous fat||29.29 ± 5.72||0.356**||0.004|
|Arm subcutaneous fat||49.99 ± 8.93||0.267*||0.035|
|Legs subcutaneous fat||46.92 ± 12.05||0.172||0.175|
|Body Skeletal Muscle Composition|
|Whole skeletal muscles||23.32 ± 2.17||-0.421***||0.001|
|Trunk skeletal muscles||17.71 ± 2.62||-0.264*||0.035|
|Arms skeletal muscles||25.26 ± 22.2||-0.158||0.213|
|Legs skeletal muscles||39.45 ± 36.95||0.153||0.229|
Pearson correlation analysis between number of ovarian follicles and other study factors shown significant ***p<0.001, **p<0.01, *p<0.05 correlation; BMI=body mass index; QUICKI=quantitative insulin-sensitivity check index; HOMA IR=homeostasis model assessment of insulin resistance
Table 1: Correlation Analysis of Number of Follicles and Anthropometric and Biochemical Factors
Correlation with insulin sensitivity and resistance
The biochemical and metabolic profile of the population shows that plasma glucose level as 101.18 ± 15.79 mg/dL, Insulin, 41.53 ± 29.45 μ IU/mL; Glucose/Insulin ratio 4.28 ± 5.68; QUICKI, 0.47 ± 0.02; Fasting Insulin Resistance percentage 140.89 ±110.4; Skeletal muscle/ Fat ratio, 39.95 ± 12; Body Fat percentage 55.57 ± 11.27; and HOMA Insulin Resistance 8.69 ± 6.81. The results in Table 1 also depicts that there is no significant correlation between number of ovarian cysts and plasma glucose, plasma insulin, glucose/insulin ratio, insulin sensitivity and insulin resistance. However, very significant (P<0.01) negative correlation is between number of ovarian cysts and skeletal muscle fat ratio.
Correlation between skeletal muscle and fat mass
In this study we obtained very interesting results as presented in the Table 1. A highly significant (P<00.001) negative correlation was noted with whole skeletal muscle mass and very significant (P<0.01) positive correlation was evident between number of ovarian cysts and total body fat, whole subcutaneous fat and trunk subcutaneous fat. The body skeletal muscle correlation analysis shows that whole skeletal muscles, and skeletal muscles in trunk, arms and legs is 23.32 ± 2.17%, 17.71 ± 2.62%, 25.26 ± 22.2% and 39.45 ± 36.95% respectively. Whereas total body fat, visceral fat, subcutaneous fat in whole, trunk, arms and legs was 37.78 ± 8.57%, 9.11 ± 6.5%, 32.82 ± 5.65%, 29.29 ± 5.72%, 49.99 ± 8.93% and 46.92 ± 12.05% respectively.
Present study was envisaged with an objective to know correlation between number of ovarian cysts and insulin resistance, sensitivity and body fat composition in infertile women with PCOS. The objectives were achieved by most widely used research tools such as HOMA-IR, QUICKI, FIR, skeletal muscle ratio, and body fat and skeletal muscle composition.
The waist circumference in Omani women in our study was 97.44 ± 15.11 cm was almost similar to 95 cm reported by Brazilian study and differing from results of Korean women. The body mass index of women involved in this study was 28.2 ± 6.08 kg/m2 indicates that they are overweight with higher inclination to obese category. These results are similar to the study carried out among an ovulatory PCOS patient where 20% of the patients were categorised to be obese. Similarly the waist/hip ratio was 0.9 ± 0.14 more than in the Iranian women ratio of 0.80 ± 0.06. The ideal body weight calculated for the study population was 55.15 ± 4.52 kg and has significantly (P<0.05) negative correlation with the number of ovarian cysts. Other factors such as waist circumference, waist/hip ratio, and body mass index are positively correlated but insignificantly.
Insulin resistance and obesity are implicated in the ovulatory dysfunction of PCOS by disrupting the hypothalamic-pituitary-ovarian axis. QUICKI, 1/insulin and glucose/insulin ratio are considered to be a reliable indicators of insulin sensitivity in most of the scientific studies whose readings decrease with an increase in resistance to insulin. Whereas, HOMA is commonly known as an indicator of resistance to insulin and its value increases with an increase in resistance to insulin. Results obtained in this study clearly show hyperglycaemia followed by hyperinsulinemia. The fasting plasma glucose level higher (101.18 mg/dL vs. 80 mg/dL for normal), fasting plasma insulin (41.52 ± 29.45 μ IU/mL vs. 5 μ IU/mL considered to be normal) showing greater insulin resistance, percentage fasting insulin resistance (140.89 ± 110.4), HOMA index (8.69 ± 6.81 vs. 1 normal) representing significantly higher insulin resistance, QUICKI (0.47 ± 0.02 vs. 0.384 normal) indicating metabolic syndrome and glucose to insulin ratio (4.28 ± 5.68 vs 16 normal) indicating hyperandrogenism and hyperinsulinemia. These results are in line with the study carried out in India among PCOS women from Delhi and Srinagar. Mean values of FPG, FPG/insulin ratio, QUICKI indexes and HOMA were significantly differing from other studies involving only PCOS cases whereas it is almost similar to the study conducted among an ovulatory PCOS patient.
Insulin resistance in PCOS is associated with skeletal muscle activity as it is the major site of insulin mediated glucose disposal and ability to synthesize, convert and degrade androgens. Preserving insulin sensitivity depends on transport of glucose in myotubes. The whole skeletal muscle was lower than the normal, with a wide variation in skeletal muscle mass in legs. It has been demonstrated that the degree of insulin resistance in young women with PCOS was similar to that seen in middle-aged patients with type 2 diabetes. The significant negative correlation of whole skeletal muscles and number of ovarian cysts substantiate the fact that insulin resistance in PCOS is related to impairment in glucose transporter activity and translocation leading to reduced muscular mass.
The percentage of total body fat and visceral fat in this study population is categorised to be very high and higher than normal respectively. Correlation analysis of data showed a significant positive correlation between number of cysts and total fat, subcutaneous whole fat, and fat in trunk. However, very significant (P<0.01) negative correlation is between number of ovarian cysts and skeletal muscle fat ratio. Simple linear regression analysis predicted a very significant (p<0.01) correlation with skeletal muscle ratio and highly significant (p<0.001) correlation with body fat percentage. These results once again proves that there is an endocrinal and metabolic abnormalities in PCOS leading to higher level of adipose tissue formation influencing fat distribution in the body. Increased adipose tissues have a tendency to increase visceral fat causing its greater accumulation in waist as seen in this study by inhibiting adipocyte differentiation, lipolysis, lipogenesis, and lipase in subcutaneous fat and beta adrenergic receptors.[35,36]
Major limitations of our study includes a relatively small number of patients considered in this cross-sectional study and majority of them were from single city and for a limited time period therefore may not be representing the general population of Oman. Therefore, the study might not be determining cause and effect relationship but it explains association of factors. We have also did not consider the menstrual changes, dietary, lifestyle, environmental, genetic and behavioural factors might have played their role in development of PCOS and other infertility in this study.
Major strength of this study include that this is the first study in its kind among Omani population to assess the correlation between number of ovarian cysts and metabolic, anthropometric and body composition. The insight gained from this study can form the basis for further studies, which can lead to the development of treatment that more directly targets insulin resistance, and hence reduce the risk of PCOS.
Taken together, the results of this cross sectional study and evidences considered we conclude that infertile women with PCOS have higher level of insulin resistance and metabolic syndrome profile, much lower level of insulin sensitivity, decreased skeletal muscle mass, very high level of total body fat and higher visceral fat content than the women with PCOS alone. There is also a significant positive correlation between number of ovarian cysts with total body fat, whole subcutaneous fat, trunk subcutaneous fat, but a significant negative correlation with skeletal muscle to fat ratio, whole skeletal muscles and ideal body weight. However, we recommend further studies by involving more patients, hospitals and regions for an extended period for concrete outcomes and their possible implementation in practice.
This work was supported by The Research Council of Oman (TRC/ FURAP/Call 3/2015-16) under the scheme FURAP- grant.
Declaration of interests
We declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. Part of the results was discussed in Academic for a conducted International conference on Medical, Medicine and Health Science, Singapore-12- 13th December, 2016.
- Burchall G, Linden MD, Teede H, Piva TJ. Haemostatic abnormalities and relationships to metabolic and hormonal status in polycystic ovarian syndrome. Trends Cardiovasc Med 2011;21:6-14.
- Nisenblat V, Norman RJ. Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes 2009;16:224-31.
- Ramaswamy S, Grace C, Mattei AA, Siemienowicz K, Brownlee W, MacCallum J, et al.Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet a/ß cell ratio and subsequent insulin secretion. Sci Rep 2016;6:27408.
- Bostanci MS, Akdemir N, Cinemre B, Cevrioglu AS, Özden S, Ünal O.Serum irisin levels in patients with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci 2015;19:4462-8.
- Afb llahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fer Soc J 2011;16:19-37.
- Vrbíková J, Grimmichová T, Dvoráková K, Hill M, Stanická S, Vondra K. Family history of diabetes mellitus determines insulin sensitivity and beta cell function in polycystic ovary syndrome. Physiol Res 2008;57:547-53.
- Gültepe I, Basaranoglu M, Süleymanoglu Y, Basaranoglu G, Beyazit F. Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia.Turk J Gastroenterol. 2016;27:62-7.
- Mutib MT, Hamdan FB, Al-Salihi AR. INSR gene variation is associated with decreased insulin sensitivity in Iraqi women with PCOs. Iran J Reprod Med 2014;12:499-506.
- Sacchinelli A, Venturella R, Lico D, Di Cello A, Lucia A, Rania E, et al.The Efficacy of Inositol and N-Acetyl Cysteine Administration (OvaricHP) in Improving the Ovarian Function in Infertile Women with PCOS with orwithout Insulin Resistance. Obstet Gynecol Int 2014;2014:141020.
- Højlund K. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Dan Med J 2014;61:B4890.
- De Leo V, Tosti C, Cappelli V, Morgante G, Cianci EA. Combination inositol and glucomannan in PCOS patients. Minerva Ginecol 2014;66:527-33.
- Ramezani TF, Daneshpour M, Hashemi S, Zarkesh M, Azizi F. Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS. Iran J Reprod Med. 2013;11:185-94.
- Garruti G, de Palo R, Rotelli MT, Nocera S, Totaro I, Nardelli C, et al. Association between follicular fluid leptin and serum insulin levels in non-overweight women with polycystic ovary syndrome.Biomed Res Int. 2014;2014:980429.
- Al Khaduri M, Al Farsi Y, Al Najjar YAA, Gowri V. Hospital-based prevalence of polycystic ovarian syndrome among Omani women, Middle East Fertility Society Journal. 2014;19:135-8.
- Ghaffarzad A, Amani R, Mehrzad Sadaghiani M, Darabi M, Cheraghian B. Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study. Int J Fertil Steril. 2016;10:29-35.
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
- Dou P, Ju H, Shang J, Li X, Xue Q, Xu Y,et al. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women. J Ovarian Res. 2016;9:51.
- Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al.Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
- Quon MJ. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocr Met 2001;86:4615-7.
- Ezeh U, Pall M, Mathur R, Azziz R. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Hum Reprod 2014;29:1508-17.
- Omron Healthcare Co. Ltd., 53, Kunotsubo, Terado-Cho, Muco, Kyoto, 617-0002, Japan. http://www.omronhealthcare-ap.com/resources/HBF-375.pdf
- Costa EC, Sa JC, Soares EM, Lemos TM, Maranhao TM, Azevedo GD. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome. Gynecol Endocrinol 2012;28:12-5.
- Oh JY, Sung YA, Lee HJ, Oh JY, Chung HW, Park H. Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome. Obesity (Silver Spring). 2010;18:593-7.
- Ozegowska K, Bogacz A, Bartkowiak-Wieczorek J, Seremak-Mrozikiewicz A, Pawelczyk L. Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism? Ginekol Pol. 2016;87:246-53.
- Hosseinpanah F, Barzin M, Erfani H, Serahati S, Ramezani Tehrani F, Azizi F. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol 2014;8:52-7.
- Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-8.
- Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. A case-control observationalstudy of insulin resistance and metabolic syndrome among the four phenotypes ofpolycystic ovary syndrome based on Rotterdam criteria. Reprod Health 2015;12:7.
- Rizzo M, Tyndall EK, Frontoni S, Jacoangeli F, Sarlo F, Panebianco F, et al. Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome. J Endocrinol Invest. 2013;36:527-30.
- Yildiz BO, Gedik O. Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia. Eur J Obstet Gynecol Reprod Biol 2001;100:62-6.
- Ganie MA, Marwaha RK, Dhingra A, Nisar S, Mani K, Masoodi S, et al. Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar. Gynecol Endocrinol. 2016;32:566-70.
- Carmina E, Campagna AM, Lobo RA. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors. Hum Reprod. 2013;28:2245-52.
- Eriksen MB, Glintborg D, Nielsen MF, Jakobsen MA, Brusgaard K, Tan Q, et al. Testosterone treatment increases androgen receptor and aromatase gene expression in myotubes from patients with PCOS and controls, but does not induce insulin resistance. Biochem Biophys Res Commun 2014;451:622-6.
- Dantas WS, Gualano B, Rocha MP, Barcellos CR, dos Reis Vieira Yance V, Marcondes JA. Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue. ScientificWorldJournal 2013;2013:178364.
- Vilmann LS, Thisted E, Baker JL, Holm JC. Development of obesity and polycystic ovary syndrome in adolescents. Horm Res Paediatr 2012;78:269-78.
- Kuchenbecker WK, Groen H, van Asselt SJ, Bolster JH, Zwerver J, Slart RH, et al. In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated with resumption of ovulation. Hum Reprod 2011;26:2505-12.
- Chitme HR, Al Azawi EK, Al Abri AM, Al Busaidi BM, Al Abdul Salam ZK, Al Taie MM, et al. Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome. Journal of Taibah University Medical Sciences 2017;1-7.